SCHEMBL8735949

SCHEMBL8735949

Fc1ccc2c(c1)c1ccncc1n2-c1ccc(-c2ccc(-c3c4ccccc4c(-c4ccc5ccccc5c4)c4ccccc34)cn2)cc1

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 2/20 0.39
PIK3CA P42336 2/20 0.39
MTOR P42345 2/20 0.39
CYP1A2 P05177 1/20 0.38
METAP2 P50579 1/20 0.38
CYP11B1 P15538 2/20 0.35
CYP11B2 P19099 2/20 0.35
AOC3 Q16853 6/20 0.35
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
AOC2 O75106 1/20 0.34
DHODH Q02127 1/20 0.33
MAPK9 P45984 2/20 0.33
MAPK10 P53779 2/20 0.33
CYP17A1 P05093 1/20 0.33
CYP19A1 P11511 1/20 0.33
NR3C1 P04150 1/20 0.32
CDK4 P11802 2/20 0.32
CDK6 Q00534 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9921665 0.81 CYP11B1 (0.38) CYP11B1CYP11B2DHODHMAPK9MAPK10
SCHEMBL12442764 0.80 PIK3CA (0.41) PIK3CDPIK3CAMTORCYP1A2METAP2
SCHEMBL18272719 0.79 CYP17A1 (0.43) PIK3CDPIK3CAMTORCYP11B1CYP11B2
SCHEMBL12169038 0.78 CYP11B1 (0.39) PIK3CDPIK3CAMTORCYP11B1CYP11B2
SCHEMBL12169065 0.78 CYP11B1 (0.38) PIK3CDPIK3CAMTORCYP11B1CYP11B2
SCHEMBL13658703 0.77 MAPK9 (0.48) CYP1A2CYP11B1CYP11B2DHODHMAPK9
SCHEMBL6114261 0.77 CYP11B1 (0.41) CYP11B1CYP11B2MAPK9MAPK10CYP17A1
SCHEMBL9890903 0.77 TUBB4A (0.41) PIK3CDPIK3CAMTORCYP1A2CYP11B1
SCHEMBL12919317 0.76 KDM4E (0.39) AOC3MEN1KMT2AMAPK10CDK4
SCHEMBL8736819 0.76 CYP11B1 (0.43) PIK3CDPIK3CAMTORCYP11B1CYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9755152-B2 Compound having substituted anthracene ring structure and pyridoindole ring structure, and organic electroluminescent device HODOGAYA CHEMICAL CO., LTD. (JP) 2017-09-05 US disclosed
US-9755152-B2 Compound having substituted anthracene ring structure and pyridoindole ring structure, and organic electroluminescent device HODOGAYA CHEMICAL CO., LTD. (JP) 2017-09-05 US disclosed
US-20150155496-A1 COMPOUND HAVING SUBSTITUTED ANTHRACENE RING STRUCTURE AND PYRIDOINDOLE RING STRUCTURE, AND ORGANIC ELECTROLUMINESCENT DEVICE HODOGAYA CHEMICAL CO LTD (JP) 2015-06-04 US disclosed
US-20150155496-A1 COMPOUND HAVING SUBSTITUTED ANTHRACENE RING STRUCTURE AND PYRIDOINDOLE RING STRUCTURE, AND ORGANIC ELECTROLUMINESCENT DEVICE HODOGAYA CHEMICAL CO LTD (JP) 2015-06-04 US disclosed
US-8927119-B2 Compound having substituted anthracene ring structure and pyridoindole ring structure, and organic electroluminescent device HODOGAYA CHEMICAL CO., LTD. (JP) 2015-01-06 US disclosed
US-8927119-B2 Compound having substituted anthracene ring structure and pyridoindole ring structure, and organic electroluminescent device HODOGAYA CHEMICAL CO., LTD. (JP) 2015-01-06 US disclosed
US-20120126220-A1 COMPOUND HAVING SUBSTITUTED ANTHRACENE RING STRUCTURE AND PYRIDOINDOLE RING STRUCTURE, AND ORGANIC ELECTROLUMINESCENT DEVICE HODOGAYA CHEMICAL CO., LTD. (JP) 2012-05-24 US disclosed
US-20120126220-A1 COMPOUND HAVING SUBSTITUTED ANTHRACENE RING STRUCTURE AND PYRIDOINDOLE RING STRUCTURE, AND ORGANIC ELECTROLUMINESCENT DEVICE HODOGAYA CHEMICAL CO., LTD. (JP) 2012-05-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150155496-A1 COMPOUND HAVING SUBSTITUTED ANTHRACENE RING STRUCTURE AND PYRIDOINDOLE RING STRUCTURE, AND ORGANIC ELECTROLUMINESCENT DEVICE SLCO2B1, PNPO, SLCO2A1 PIK3CD 2470/4885PIK3CA 2980/4885MTOR 2547/4885
US-20120126220-A1 COMPOUND HAVING SUBSTITUTED ANTHRACENE RING STRUCTURE AND PYRIDOINDOLE RING STRUCTURE, AND ORGANIC ELECTROLUMINESCENT DEVICE SLCO2B1, PNPO, SLCO2A1 PIK3CD 2470/4885PIK3CA 2980/4885MTOR 2547/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.